Active Pharmaceutical Api Intermediate Bulk Drug Manufacturer Company

explore our main services

Hebei Weimiao Import and Export Trade Co., Ltd. is a specialized and dynamic company dedicated to the research and development, manufacturing, and marketing of APIs (Active Pharmaceutical Ingredients) and pharmaceutical intermediates. With a commitment to excellence, we strive to deliver high-quality bulk pharmaceutical products that meet stringent industry standards. Our expertise lies in the production of essential components for the pharmaceutical sector, contributing to the advancement of healthcare solutions. Trust in Hebei Weimiao for reliable and innovative solutions in the field of API and pharmaceutical intermediate manufacturing.

we advice to choose
a right decision

our products

we'll ensure you always get
best results.

latest case studies

Hebei Weimiao Import and Export Trade Co., Ltd. showcases its strengths in precision manufacturing, customization, and global regulatory compliance, positioning itself as a reliable api pharmaceutical company and pharmaceutical intermediates manufacturer.

Exhibition
Exhibition
laboratory
laboratory
scientific research
scientific research
Experimental equipment
Experimental equipment

Inquiry for pricelist

Since its establishment, our factory has been developing first world class products with adhering the principle of quality first. Our products have gained excellent reputation in the industry and valuabletrusty among new and old customers..

submit now

latest news & blogs

Apr . 25, 2024
What is an API?

The safety and efficacy of a drug depend on the quality of its API. Poorly manufactured or unsafe APIs may result in harmful consequences, including death. Therefore, they are required to be regulated. APIs must adhere to strict safety and quality standards set by the manufacturing country. Even if the manufacturing is outsourced, APIs must follow the stringent rules of the concerned health authority. For example, if the API is manufactured in Korea or Japan for distribution in the US, it will still be inspected under the FDA guidelines.
details
Apr . 25, 2024
WHAT ARE APIS?

While the number of available prescription or over-the-counter drugs (OTC) under different names increases daily, the situation differs in the case of APIs. Considering how expensive the steps to introducing a new drug to the market are, there isn’t a great number of new APIs being introduced. An API is sold under only one name: the nonproprietary name.To avoid confusion in this market, which potentially would have dangerous consequences, WHO, in cooperation with national drug safety agencies worldwide, came up with a list of non-proprietary names back in 1953. The organization revises the list regularly, and you can send them a request for new International Nonproprietary Names (INN).So, everywhere in the world, Ramipril is sold as Ramipril, and that API can’t be bought under any other name. Drug manufacturers can sell their drugs under any name they want, but they must put the API name right under the brand name.
details
Apr . 25, 2024
Active pharmaceutical ingredient (API - Part II)

an extracted and purified active component of the cannabis plant (for example a cannabinoid)an extract of specified parts of the cannabis planta trituration of specified parts of the cannabis plantthe dried flower of the cannabis plant separated from leaves and stemThe term 'API starting material' refers to the starting material from which the API is made, not to the API.The manufacture of the API is required to be in compliance with Part II of the PIC/S Guide to GMP, as well as the relevant parts of the Annexes to the PIC/S Guide to GMP.
details